Celestra Inc

352770

Company Profile

  • Business description

    Celestra Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology. It offers a genome-based, early cancer diagnostic service through technology for multi-omics analysis and simultaneous detection of CTC and cfDNA in the blood based.

  • Contact

    Building 110, UNIST, 50
    Suite 301-3, UNIST-gil, Eonyang-eup, Ulju-gun
    Ulsan44919
    KOR

    T: +82 7082866966

    http://www.clinomics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    48

Stocks News & Analysis

stocks

Are small caps finally back?

Does renewed investor interest point to a structural shift in the underperforming factor?
stocks

Chart of the Week: Modest earnings growth at odds with overvalued bank shares

The latest update from our Industry Pulse report.
stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,329.1050.900.55%
CAC 408,236.7329.860.36%
DAX 4024,101.9349.20-0.20%
Dow JONES (US)46,590.41334.33-0.71%
FTSE 1009,571.6156.610.59%
HKSE25,967.98186.210.72%
NASDAQ22,740.40213.27-0.93%
Nikkei 22548,641.61666.18-1.35%
NZX 50 Index13,377.1070.660.53%
S&P 5006,699.400.000.00%
S&P/ASX 2009,032.8046.600.52%
SSE Composite Index3,922.418.650.22%

Market Movers